RSS2.0

Cipher Pharmaceuticals enters into U.S. licensing and distribution agreement for Lipofen

Tuesday, July 10, 2007

Cipher Pharmaceuticals Inc. today announced that it has entered into a definitive licensing and distribution agreement with ProEthic Pharmaceuticals Inc , under which Cipher has granted ProEthic the exclusive right to market, sell and distribute Lipofen in the United States, its territories and possessions.
From: biz.yahoo.com

0 comments: